T
Theia Clinical Research Centers | Temple Terrace, FL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
ABX464
RO7790121
Obefazimod
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 3 total trials
This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance...
Enrolling
Moderately to Severely Active Crohns Disease
Drug: RO7790121
Drug: Placebo
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinica...
Enrolling
Ulcerative Colitis
Drug: ABX464
Drug: Placebo
This study has 3 treatment phases, a 12-Week Induction Phase, a 40-Week Maintenance Phase, and a 48-Week Extension Phase.The objective is to evaluate...
Enrolling
Moderately to Severely Active Crohn Disease
Drug: Obefazimod
Other: Placebo
Trial sponsors
A
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems